Elderly donor liver grafts are not associated with a higher incidence of biliary complications after liver transplantation: results of a national multicenter study.

Abstract:

BACKGROUND:Liver transplantation with livers grafts from elderly donors has been associated with a higher risk of biliary complications. The aim of this study was to examine whether our national protocol could contribute to a lower incidence of biliary complications. METHODS:All adult recipients in the Netherlands transplanted with a liver from an elderly donor (≥ 65 yrs; n = 68) in the period January 2000-July 2011 were matched with recipients of a liver from a donor <65 yr (n = 136). Outcome parameters were 90-d, one-yr, and three-yr patient/graft survival rates, biliary complications (non-anastomotic stricture, anastomotic stricture, biliary leakage, and post-transplant cholangitis), and postoperative hepatic ischemic injury serum markers (AST/ALT). RESULTS:The median cold ischemia time (CIT) was 7:25 (h:min) in the group recipients of an elderly donor liver graft. Ninety-day, one-yr, and three-yr patient/graft survival rates were similar between the group with an elderly donor liver and their younger controls. Moreover, no differences were found in the incidence of biliary complications and postoperative levels of AST/ALT between the two groups. CONCLUSION:Transplantation of livers from elderly donors (≥ 65 yr) is not associated with a higher incidence of biliary complications, in a national policy wherein the CIT is kept short.

journal_name

Clin Transplant

journal_title

Clinical transplantation

authors

Westerkamp AC,Korkmaz KS,Bottema JT,Ringers J,Polak WG,van den Berg A,van Hoek B,Metselaar HJ,Porte RJ

doi

10.1111/ctr.12569

subject

Has Abstract

pub_date

2015-07-01 00:00:00

pages

636-43

issue

7

eissn

0902-0063

issn

1399-0012

journal_volume

29

pub_type

杂志文章,多中心研究
  • The impact of obesity in renal transplantation: an analysis of paired cadaver kidneys.

    abstract:BACKGROUND:Previous studies indicate that obesity is a risk factor in renal transplantation. However, these analyses did not control for variable donor factors that may strongly influence outcome. To control for donor variables such as age, cause of death, procurement techniques, preservation methods, cold ischaemia ti...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1034/j.1399-0012.2002.01080.x

    authors: Yamamoto S,Hanley E,Hahn AB,Isenberg A,Singh TP,Cohen D,Conti DJ

    更新日期:2002-08-01 00:00:00

  • Low molecular weight heparin dosing and monitoring in solid organ transplant recipients.

    abstract::Anti-Xa monitoring for low molecular weight heparin (LMWH) is currently recommended in obese, renally impaired, and pregnant patients. Substantial evidence indicates that solid organ transplant (SOT) patients are at an increased risk of renal impairment, thus representing a population at risk of LMWH accumulation. The...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12240

    authors: Moten MA,Gaber AO,Putney D,Patel SJ

    更新日期:2013-11-01 00:00:00

  • Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience.

    abstract::Porto-pulmonary hypertension with moderate or severe pulmonary arterial hypertension (PAH) is viewed as a contraindication to liver transplantation (LT) because of associated poor outcomes; however, patients with biliary atresia (BA) are generally good candidates for LT. Ten patients with moderate/severe PAH underwent...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12415

    authors: Ogawa E,Hori T,Doi H,Segawa H,Uemoto S

    更新日期:2014-09-01 00:00:00

  • Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.

    abstract:BACKGROUND:Stem cell-based therapy has received attention as a possible alternative to organ transplantation. The aim of this study was to assess the safety and efficacy of autologous transplantation of bone marrow (BM)-derived stromal cells in post-HCV liver cirrhosis patients. METHODOLOGY:10 × 10(6) of isolated huma...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12179

    authors: Amin MA,Sabry D,Rashed LA,Aref WM,el-Ghobary MA,Farhan MS,Fouad HA,Youssef YA

    更新日期:2013-07-01 00:00:00

  • Diffuse large B-cell lymphoma in a renal allograft associated with Epstein-Barr virus in the recipient: a case report and a review of lymphomas presenting in a transplanted kidney.

    abstract::The purpose of this review was to evaluate the case reports with lymphoproliferative disorders exclusively localized in the allograft transplanted kidney. We also report a rare case of diffuse large B-cell lymphoma originated from the lymphocytes of the recipient with exclusive localization in the kidney allograft. We...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/j.1399-0012.2008.00804.x

    authors: Cobo F,García C,Talavera P,Ruiz-Cabello F,Bravo J,Concha A

    更新日期:2008-07-01 00:00:00

  • Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases.

    abstract:INTRODUCTION:Either deceased or living-related renal transplantation constitutes the best therapeutic option for patients with end-stage renal disease. In this retrospective study, an attempt to identify parameters that affect allograft survival in living donor renal transplantation was made. METHODS:Between January 2...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12219

    authors: Kostakis ID,Moris DN,Barlas A,Bokos I,Darema M,Theodoropoulou E,Karaolanis G,Kostakis A,Boletis I,Zavos G

    更新日期:2013-11-01 00:00:00

  • Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil.

    abstract:UNLABELLED:Enteric-coated mycophenolate sodium (MPS) has been developed to help circumvent the upper gastrointestinal side-effects of mycophenolic acid by facilitating drug release in the small intestine. Many questions regarding the side-effect profile of MPS remain. Therefore, the purpose of this study is to review a...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/j.1399-0012.2008.00820.x

    authors: Hardinger KL,Hebbar S,Bloomer T,Murillo D

    更新日期:2008-09-01 00:00:00

  • Erythrocytosis after renal transplantation: risk factors and relationship with GFR.

    abstract::Post-transplant erythrocytosis (PTE) has been increasingly recognized as a complication of kidney transplantation, and several risk factors have been defined. Recent evidence suggests renal function may also play a role in hematological recovery after transplantation and risk of PTE. In this study of kidney transplant...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:

    authors: Nankivell BJ,Allen RD,O'Connell PJ,Chapman JR

    更新日期:1995-10-01 00:00:00

  • Multidrug-resistant Acinetobacter baumannii infections in lung transplant patients in the cardiothoracic intensive care unit.

    abstract:BACKGROUND:Multidrug-resistant (MDR) gram-negative bacteria are a growing threat to solid organ transplantation (SOT) patients in the intensive care unit (ICU). We aimed to examine the mortality rates of gram-negative MDR bacterial infection in SOT patients compared with patient population undergoing other cardiothorac...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12575

    authors: Biderman P,Bugaevsky Y,Ben-Zvi H,Bishara J,Goldberg E

    更新日期:2015-09-01 00:00:00

  • Post-transplant lymphoproliferative disorders after live donor renal transplantation.

    abstract::The development of post-transplant lymphoproliferative disorders (PTLD) is a well-recognized complication of solid organ transplantation in patients receiving immunosuppressive therapy. The literature on PTLD in live renal allograft recipients is scarce and most of the data pertains to PTLD in cadaveric transplants. A...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/j.1399-0012.2005.00406.x

    authors: Jain M,Badwal S,Pandey R,Srivastava A,Sharma RK,Gupta RK

    更新日期:2005-10-01 00:00:00

  • Echinocandin use in lung transplant recipients.

    abstract:BACKGROUND:Invasive fungal infections (IFI) are associated with significant morbidity and mortality in lung transplant recipients (LTRs). However, data outlining use of echinocandins in prophylaxis and therapy of LTRs are limited. METHOD:A single-center retrospective cohort study on all LTRs from January-2010 to Decem...

    journal_title:Clinical transplantation

    pub_type: 临床试验,杂志文章

    doi:10.1111/ctr.13437

    authors: Al Jishi Y,Rotstein C,Kumar D,Humar A,Singer LG,Keshavjee S,Husain S

    更新日期:2018-12-01 00:00:00

  • Effect of storage temperature on early graft function following liver transplantation.

    abstract::The effect of storage temperature on early graft function following liver transplantation was investigated by analyzing the results following transplantation during three periods in which different techniques for graft storage were used. The techniques involved ice-packing (period 1), storage in a standard operating ...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:

    authors: Morino M,Adam R,Diamond T,Castaing D,Reynes M,Bismuth H

    更新日期:1992-04-01 00:00:00

  • Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.

    abstract:INTRODUCTION:Atherosclerosis is a serious complication and leading cause of mortality in renal transplant recipients (RTRs). Hyperlipidemia may be associated with progression of renal disease and chronic allograft dysfunction. Similarities in the pathogenesis of glomerulosclerosis and atherosclerosis have been proposed...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/j.1399-0012.2004.00162.x

    authors: Kahraman S,Kiykim AA,Altun B,Gençtoy G,Arici M,Gulsun M,Erdem Y,Yasavul U,Turgan C,Cağlar S

    更新日期:2004-06-01 00:00:00

  • A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation.

    abstract:BACKGROUND:Cyclosporine (CsA) and tacrolimus (Tac) in heart transplantation (HTx) have been compared but with certain drawbacks. We compared both drugs in a prospective analysis with medium-term follow-up. METHODS:Hundred and six patients were randomized to receive CsA or Tac (53 per group). Target levels of CsA were ...

    journal_title:Clinical transplantation

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1399-0012.2010.01309.x

    authors: Sánchez-Lázaro IJ,Almenar L,Martínez-Dolz L,Buendía-Fuentes F,Agüero J,Navarro-Manchón J,Vicente JL,Salvador A

    更新日期:2011-07-01 00:00:00

  • Changing the paradigm of organ utilization from PHS increased-risk donors: an opportunity whose time has come?

    abstract::Approximately 8-11% of all organ donors are classified by Public Health Service (PHS) as increased-risk. The proportion of PHS increased-risk donors is on the rise. At the University of Washington Medical Center, in 2014, the proportion of transplants from PHS increased-risk donors was 28% of liver transplants and 23%...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12582

    authors: Sibulesky L,Javed I,Reyes JD,Limaye AP

    更新日期:2015-09-01 00:00:00

  • Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.

    abstract::As experience with tacrolimus (FK506, Prograf) accumulates and reduced rejection rates are increasingly demonstrated, some transplant centers are adopting tacrolimus-based primary immunosuppressive regimens for their patients undergoing pancreas/kidney transplantation. The guidelines provided in this article based on ...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:

    authors: Gruessner RW,Bartlett ST,Burke GW,Stock PG

    更新日期:1998-06-01 00:00:00

  • The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation.

    abstract:BACKGROUND:It has been shown that glomerulonephritis (GN) recurrence affects graft survival more than acute rejection. Thus, we assessed allograft survival after biopsy-confirmed diagnosis of acute rejection or recurrent GN in current era of immunosuppression. METHODS:Allograft survival following a biopsy diagnosis of...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.13738

    authors: Singh T,Astor BC,Zhong W,Mandelbrot DA,Maursetter L,Panzer SE

    更新日期:2019-12-01 00:00:00

  • Orthotopic placement of a segmental pancreas graft for transplant: a case report.

    abstract::Pancreas retransplantation has become more frequent and represents a technical challenge for surgeons. Knowledge of alternative surgical options could be useful in difficult cases. We present a case of brutal diabetes mellitus in a patient with severe vascular disease that underwent a third pancreas transplant. Diffic...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/j.1399-0012.2009.01149.x

    authors: Garcia-Roca R,Humar A,Sturdevant M,Kobayashi T,Dunn T,Kandaswamy R,Sutherland D

    更新日期:2010-05-01 00:00:00

  • Pseudoaneurysm of the Y-graft/iliac artery anastomosis following pancreas transplantation: a case report and review of the literature.

    abstract::Transplant-related aneurysms are an unusual complication following pancreas transplantation. We present a case of a pseudoaneurysm developing in a recipient 6 months after bladder-drained pancreas transplantation. The pseudoaneurysm was incidentally found during ultrasonographic evaluation in preparation for a pancrea...

    journal_title:Clinical transplantation

    pub_type: 杂志文章,评审

    doi:10.1034/j.1399-0012.2001.150113.x

    authors: Verni MP,Leone JP,DeRoover A

    更新日期:2001-02-01 00:00:00

  • Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?

    abstract::We report of twins who underwent hematopoietic stem cell transplantation (HSCT) for neonatal acute leukemia. Hospitalized in the same room from the time the first one demonstrated respiratory symptoms, they both developed Pneumocystis jiroveci (formerly carinii) pneumonia (PCP) 2 wk apart. This observation suggests th...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/j.1399-0012.2005.00346.x

    authors: Resnick IB,Averbuch D,Aker M,Engelhard D

    更新日期:2005-06-01 00:00:00

  • Survival benefit of renal transplantation in octogenarians.

    abstract:BACKGROUND:Elderly patients are the fastest growing population requiring renal replacement therapy. As previous studies have shown a survival benefit of kidney transplantation compared to dialysis for end-stage renal disease, we sought to evaluate if this survival benefit extends to octogenarians. METHODS:This was a s...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.14074

    authors: Ravichandran BR,Sparkes TM,Masters BM,Thomas B,Demehin M,Bromberg JS,Haririan A

    更新日期:2020-11-01 00:00:00

  • Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.

    abstract::We sought to determine the incidence, risk factors, and consequences of acute rejection (AR) after conversion from a calcineurin inhibitor (CNI) to a proliferation signal inhibitor (PSI) in maintenance heart transplantation. Relevant clinical data were retrospectively obtained for 284 long-term heart transplant recipi...

    journal_title:Clinical transplantation

    pub_type: 杂志文章,多中心研究

    doi:10.1111/ctr.12241

    authors: González-Vílchez F,Vázquez de Prada JA,Paniagua MJ,Almenar L,Mirabet S,Gómez-Bueno M,Díaz-Molina B,Arizón JM,Delgado J,Pérez-Villa F,Crespo-Leiro MG,Martínez-Dolz L,Roig E,Segovia J,Lambert JL,Lopez-Granados A,Escribano P

    更新日期:2013-11-01 00:00:00

  • Mast cell phenotypes in the allograft after lung transplantation.

    abstract:BACKGROUND:The burden of mast cell (MC) infiltration and their phenotypes, MC-tryptase (MCT ) and MC-tryptase/chymase (MCTC ), after lung transplantation (LT) has not been evaluated in human studies. METHODS:We reviewed 20 transbronchial lung biopsy (TBLB) specimen from patients with early normal allograft (<6 months ...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12758

    authors: Banga A,Han Y,Wang X,Hsieh FH

    更新日期:2016-07-01 00:00:00

  • HMGCoA reductase inhibitors and omega-3 fatty acids as adjunctive agents in maintenance immunosuppression after solid organ transplantation.

    abstract::Omega-3 fatty acids have been shown to play a role in preventing development of both acute and chronic rejection. New evidence also suggests that HMGCoA reductase inhibitors may have an immunomodulatory effect and may decrease the incidence of rejection in both animal and human transplant models. Omega-3 fatty acids a...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:

    authors: Katznelson S,Wilkinson AH

    更新日期:1995-06-01 00:00:00

  • Post-transplantation diabetes mellitus: evaluation of treatment strategies.

    abstract:BACKGROUND:Post-transplantation diabetes mellitus (PTDM) is a serious complication after kidney transplantation, but evidence regarding long-term outcomes of treatment regimens remains scarce. AIM AND METHODS:The aim of this retrospective cohort analysis was to assess the long-term efficiency and safety of antidiabeti...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12541

    authors: Haidinger M,Antlanger M,Kopecky C,Kovarik JJ,Säemann MD,Werzowa J

    更新日期:2015-05-01 00:00:00

  • Pathology and etiology of chronic rejection of the heart.

    abstract::As there are other lesions in the cardiac allografts of long-term survivors, it is best to refer to the vascular lesion as "graft vascular disease". Graft vascular disease may be evident as early as 3 months after cardiac transplantation and may cause death in the recipient as late as 22 years post-transplant. The dis...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:

    authors: Billingham ME

    更新日期:1994-06-01 00:00:00

  • Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.

    abstract::It is unclear whether a concomitant kidney transplant grants survival benefit to liver transplant (LT) candidates with renal dysfunction (RD). We retrospectively studied LT candidates without RD (n = 714) and LT candidates with RD who underwent either liver transplant alone (RD-LTA; n = 103) or simultaneous liver-kidn...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.12479

    authors: Brennan TV,Lunsford KE,Vagefi PA,Bostrom A,Ma M,Feng S

    更新日期:2015-01-01 00:00:00

  • Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes.

    abstract:BACKGROUND:More data are needed regarding the incidence, risk factors, and outcomes for Clostridioides difficile infection (CDI) and colonization in patients undergoing an autologous hematopoietic stem cell transplantation (AHSCT). METHODS:We studied 472 consecutive patients admitted for a first AHSCT and conducted a ...

    journal_title:Clinical transplantation

    pub_type: 杂志文章

    doi:10.1111/ctr.13712

    authors: Ford CD,Lopansri BK,Coombs J,Webb BJ,Nguyen A,Asch J,Hoda D

    更新日期:2019-11-01 00:00:00

  • Prediction, prevention, and management of delayed graft function: where are we now?

    abstract::Delayed graft function (DGF) remains a major barrier to improved outcomes after kidney transplantation. High-risk transplant recipients can be identified, but no definitive prediction model exists. Novel biomarkers to predict DGF in the first hours post-transplant, such as neutrophil gelatinase-associated lipocalin (N...

    journal_title:Clinical transplantation

    pub_type: 杂志文章,评审

    doi:10.1111/ctr.12832

    authors: Nashan B,Abbud-Filho M,Citterio F

    更新日期:2016-10-01 00:00:00

  • Brain natriuretic peptide and right heart dysfunction after heart transplantation.

    abstract::Heart transplantation (HT) should normalize cardiac endocrine function, but brain natriuretic peptide (BNP) levels remain elevated after HT, even in the absence of left ventricular hemodynamic disturbance or allograft rejection. Right ventricle (RV) abnormalities are common in HT recipients (HTx), as a result of engra...

    journal_title:Clinical transplantation

    pub_type: 杂志文章,评审

    doi:10.1111/ctr.12969

    authors: Talha S,Charloux A,Piquard F,Geny B

    更新日期:2017-06-01 00:00:00